Mereo BioPharma Group PLC Stock London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Sales 2024 * | 27.5M 34.38M | Sales 2025 * | 12.5M 15.63M | Capitalization | 313M 391M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10M | Net income 2025 * | -28M -35.01M | EV / Sales 2024 * | 6.71 x |
Net cash position 2024 * | 128M 161M | Net cash position 2025 * | 142M 178M | EV / Sales 2025 * | 13.7 x |
P/E ratio 2024 * |
-298
x | P/E ratio 2025 * |
-60.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 53 | 15-02-28 | |
John P. Richard
FOU | Founder | 66 | 15-02-28 |
Founder | 64 | 15-07-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 19-04-22 |
Director/Board Member | - | 22-11-09 | |
Director/Board Member | 59 | 19-04-22 |
1st Jan change | Capi. | |
---|---|---|
-3.32% | 104B | |
+0.05% | 97.42B | |
+1.37% | 22.2B | |
-18.28% | 21.23B | |
-10.72% | 18.33B | |
-42.83% | 16.35B | |
-17.29% | 15.06B | |
+3.57% | 13.98B | |
+27.78% | 11.66B |